// App-Quantinova.ai

Abstract 12000 : A Novel Human Arterial Transcriptomic Signature Associated With Major Adverse Cardiovascular Events and Oxidative Stress

Researchers

Presenter

  • Christos Kotanidis

Principal Investigators

  • Helen Lockstone

  • Benjamin Wright

  • Nadia Akawi

  • Ioannis Akoumianakis

  • Ileana Badi

  • Murray Polkinghorne

  • Shakil Farid

  • Vivek Srivastava

  • George Krasopoulos

  • Keith M Channon

  • Charalambos Antoniades

Medical Centers

  • Dept of Cardiothoracic Surgery, Dept of Cardiothoracic Surgery, Oxford Univ Hosps NHS Foundation Trust, Oxford, United Kingdom

  • Div of Cardiovascular Medicine, Radcliffe Dept of Medicine, Univ of Oxford, Oxford, United Kingdom

  • Div of Cardiovascular Medicine, Radcliffe Dept of Medicine, Div of Cardiovascular Medicine, Radcliffe Dept of Medicine, Univ of Oxford, Oxford, United Kingdom

  • Dept of Cardiothoracic Surgery, Oxford Univ Hosps NHS Foundation Trust, Oxford, United Kingdom

  • Wellcome Trust Cntr for Human Genetics, Wellcome Trust Cntr for Human Genetics, Univ of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Congestive heart failure

  • Hypertension

  • Stroke

Biomarkers

  • Ischemia Modified Albumin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A